5 results match your criteria: "Katholisches Klinikum Bochum Sankt Josef-Hospital[Affiliation]"
Improve Mental Health (Improve-MH) in refugee families using a culturally adapted, general practitioner-delivered psychotherapeutic intervention combined with Triple P Online parenting programme: study protocol of a multicentre randomised controlled trial.
BMJ Open
September 2024
Faculty of Psychology, Mental Health Research and Treatment Center, Ruhr University Bochum, Bochum, Germany.
Article Synopsis
- Germany and the EU have seen over 1.6 million refugees since 2014, with many facing challenges like discrimination, poor living conditions, and mental health issues, especially among parents.
- The study aims to improve mental health in refugee parents through a randomized controlled trial involving 188 participants, providing a 10-week intervention focused on parenting skills and mental health support, compared to standard treatment.
- The research is ethically approved and will assess outcomes at multiple stages, running from February 2019 to July 2025, to evaluate both parental and child mental health improvements.
Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy.
J Neurol Neurosurg Psychiatry
May 2024
Universitätsklinik für Neurologie der Ruhr-Universität Bochum, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Nordrhein-Westfalen, Germany.
Background: After natalizumab discontinuation severe relapses can occur despite pregnancy, but third trimester exposure is associated with neonatal haematological abnormalities (HA). The best time point for stopping natalizumab during pregnancy is unclear.
Methods: Prospective, observational cohort with 350 natalizumab exposed pregnancies from the German Multiple Sclerosis and Pregnancy Registry.
Increased incidence of GERD in GLP-1 treated patients: fact or artefact?
Gut
August 2024
Department of Internal Medicine, Gastroenterology and Diabetes, Augusta-Kranken-Anstalt gGmbH, Bochum, Germany
Impact of concomitant oral glucose-lowering medications on the success of basal insulin titration in insulin-naïve patients with type 2 diabetes: a systematic analysis.
BMJ Open Diabetes Res Care
July 2023
Diabetes, Endocrinology, Metabolism Section, Department of Medicine I, Katholisches Klinikum Bochum Sankt Josef-Hospital, Ruhr-University Bochum, Bochum, Germany
Basal insulin treatment for type 2 diabetes is usually initiated on a background of oral glucose-lowering medications (OGLM). We wanted to examine the influence of various OGLMs on fasting plasma glucose (FPG) and hemoglobin A (HbA) values achieved after titration. A PubMed literature search retrieved 42 publications (clinical trials introducing basal insulin in 17 433 insulin-naïve patients with type 2 diabetes on a defined background of OGLM) and reporting FPG, HbA, target achievement, hypoglycemic events, and insulin doses.
View Article and Find Full Text PDF